KPE-14170-62515
3 vaccinations
2 coded responses
13 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 968 / HI
- Registered
- 2021-01-03
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-03
Registered in v-safe
- 2021-01-03
- 2021-01-06
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-17
- 2021-01-20
- 2021-01-21
-
2021-02-04
Survey response — day 21, dose 2MedDRA: Arthralgia — Feeling: FairFree text: Joint pain increasing in left knee and left elbowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-25
- 2021-04-17
- 2021-07-17
-
2022-03-02
Dose 3 — Pfizer-BioNTech
-
2022-04-18
Survey response — day 42, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2023-03-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2022-03-02 | Pfizer-BioNTech | No |
Free text
Release 3 — day 21, dose 2
Symptoms: Joint pain increasing in left knee and left elbow
Release 11 — day 42, dose 3
Symptoms: Fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release